Recently, for innovative biotech companies in Massachusetts have a new source of funding for Russian investment companies and funds. In the development of such cooperation benefit all market participants, and may therefore organized the conference has become one of the most visited events USRCCNE recently and attracted about 120 participants.
U.S. Biotechnology Companies Interested In Partnership With Russian Venture Funds